Nomura Holdings’s VanEck Pharmaceutical ETF PPH Stock Holding History

Nomura Holdings’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-800	Closed	-$38K	–	2236
2013 Q3	$38K	Buy	+800	New	+$37.9K	﹤0.01%	2144

Other funds holding PPH

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MIM

Macroview Investment Management Bethesda, Maryland $144M AUM 19.29% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Columbia Capital Fullerton, California $91.6M AUM 27.93% 1-Year Est. Return

Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

MWR

McAdams Wright Ragen Seattle, Washington $1.79B AUM 13.95% 1-Year Est. Return

Nomura Holdings's PPH Position: Q4 2013 in Review

Nomura Holdings sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2013, closing a stake of 800 shares — an estimated $38K sold.

Nomura Holdings first reported a position in PPH in Q3 2013 and held it in 1 quarter. The position peaked at $38K in Q3 2013. 48 funds tracked by Wall St. Rank hold PPH as of Q4 2013.

Nomura Holdings reported no remaining VanEck Pharmaceutical ETF position as of Q4 2013 after selling out during the quarter.
Nomura Holdings sold 800 VanEck Pharmaceutical ETF shares in Q4 2013, an estimated $38K.
Nomura Holdings first reported a position in VanEck Pharmaceutical ETF in Q3 2013 and held it in 1 quarter.
Nomura Holdings's VanEck Pharmaceutical ETF position peaked at $38K in Q3 2013.
48 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2013.

Based on Nomura Holdings's 13F filing for Q4 2013, filed 14 Feb 2014.